From Viral Detection to Disease Measurement: Lessons from COVID-19
The COVID-19 pandemic demonstrated a fundamental distinction between detecting an infectious stimulus and measuring the disease produced by that stimulus. SARS-CoV-2 establishes infection, whereas COVID-19 reflects the interaction among viral replication, host immunity, inflammation, endothelial dysfunction, coagulation and tissue injury. These processes are related but are not interchangeable measurements. A positive molecular test establishes evidence of viral genetic material; it does not, by itself, quantify tissue injury, systemic thromboinflammation or disease severity. Similarly, individual biomarkers measure components of a biological response rather than necessarily defining the complete disease state. Clinical outcomes, including hospitalization and death, provide important measures of consequence but do not necessarily identify the mechanisms that produced them. COVID-19 therefore provides a case study in measurement fidelity: the quantity measured must be distinguished from the biological process that the investigator seeks to understand. Viral evolution, changing population immunity, vaccination, immune imprinting and human behaviour further demonstrate that the relationship between infection and disease changes over time. Future pandemic preparedness should integrate pathogen detection with mechanistically appropriate measurements of host response, tissue injury and clinical outcome, while maintaining explicit boundaries between measurement, inference and causation.
Authors
- Richard M. Fleming (ORCID: https://orcid.org/0000-0001-9964-1518)
- NRP BA BS Matthew R Fleming (ORCID: https://orcid.org/0000-0002-9974-0468)
Publication Details
- Journal
- QJM
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1093/qjmed/hcag318
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00